Chemylix is uniquely positioned to
seed the development of new medicines that bring a
genuine therapeutic benefit to patients.
Indeed, the most effective strategy to engineer a drug that effectively
responds to an unmet medical need is to start off with a molecule that
exhibits a
truly innovative chemical structure.
For a
new molecular key has the potential to unlock novel biological mechanisms that eventually actuate a distinctive therapeutic effect.
New structures power new cures: our
Molecular Foundry™ synthetic engine delivers the former.
Designed to explore a new frontier in chemistry, it steers the process
of drug discovery towards pristine molecular domains and provides
access to the raw, virgin material out of which the final drug is to be
carved.
Hence, although we operate upstream of the R&D workflow, the reach
of
our technology and the quality of
our product impact the entire drug development sequence.
They are eventually distilled down to market approval and ultimately patients, directly affected by
the efficacy and safety profiles of the afforded therapy.
